Synergy in antibacterial activities of Ampicillin trihydrate, stabilized with a synthetic aluminum-magnesium silicate and immune-stimulants, on resistant <i>Escherichia coli</i> infection — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Synergy in antibacterial activities of Ampicillin trihydrate, stabilized with a synthetic aluminum-magnesium silicate and immune-stimulants, on resistant <i>Escherichia coli</i> infection
Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
,
Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
,
Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
,
Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
,
Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
,
Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
,
Department of Veterinary Physiology and Pharmacology, University of Nigeria, Nsukka, Nigeria
,
Department of Veterinary Parasitology and Entomology, University of Nigeria, Nsukka, Nigeria
1 Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
2 Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
3 Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
4 Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
5 Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
6 Department of Veterinary Medicine, University of Nigeria Nsukka, Nigeria;
7 Department of Veterinary Physiology and Pharmacology, University of Nigeria, Nsukka, Nigeria
8 Department of Veterinary Parasitology and Entomology, University of Nigeria, Nsukka, Nigeria
To treat resistant Escherichia coli infection in chicks, Ampicillin was stabilized with a synthetic aluminum-magnesium silicate (AMS) to prolong its bioavailability. Its dose was also reduced to minimize adverse side effects. Vitamins A, C, E and Selenium levels in the chicks’ feeds were increased to enhance immune response of the chicks. E. coli coloning forming units, per ml of bile of the chicks, treated with Ampicillin and with Ampicillin in AMS, were: 228800.00 ± 90103.50 and 134500.00 ± 44937.97 at 10 mg/kg, 104400.00 ± 36024.44 and 34800.00 ± 8014.97 at 7.5 mg/kg, 198400.00 ± 129301.80 and 156800.00 ± 1 09392.70 at 5 mg/kg. Mean bacterial loads of the untreated groups, fed normal feed and those fed the fortified feed were 824400.00 ± 322424.80 and 534800.00 ± 277832.80. At 7.5 mg/kg. Ampicillin in the AMS, effectively (P < 0.05) treated resistant E. coli infection in chicks, fed immune-stimulants, with the infection rate reduced by 95.8%.
KeywordsProlonging Bioavailability of DrugsMinimizing Side Effects of DrugsEnhancing Immune Responses of Patients
NTP (1987) Abstract for Tr-318-Ampicillin Trihydrate (CASRN 7177-48-2) toxicology and carcinogenesis stu dies of Ampicillin Trihydrate (CAS No. 7177-48-2) in F344/N Rats and 36C 3F, Mice (Gavage studies). NTP Study Reports, National Toxicological Program, USA Government.
Ewers, C., Anto, E.M., Diehi, I., Philip, H.C. and Wieler, L.H. (2004) Molecular epidemiology of Avian pathogenic Escherichia coli isolated from colisepticaemia in poultry. Veterinary Microbiology, 104, 91-101. http://dx.doi.org/10.1016/j.vetmic.2004.09.008
Johnson, J.R., Sannes, M.R., Croy, C., Johnson, B., Clabots, C., Kustowski, M.A., Bender, J., Smith, K.E., Winokur, P.L. and Belongia, E.A. (2007) Antimicrobial drugresistant Esherichia coli from human and poultry products Minnesota and Wisconsin. Emerging Infectious Diseases, 13, 1576-1585. http://dx.doi.org/10.3201/eid1306.061576
Butaye, P. and Jasson, V. (2000) E. coli infections. CODACERVA Publications. www.coda-cerva.com
Murray, P.R. (2007) Mannual of clinical microbiology. 9th Edition, ASM Press, Washington DC.
Diarra, M.S., Silversides, F.G., Diarrasouba, F., Pritchard, J., Masson, L., Brouseau, R., Bonnet, C., Delaquis, P., Bach, S., Skura, B.J. and Topp, E. (2007) Impact of food supplementation with antimicrobial agents on growth performance of broiler chickens, Clostridium perfringes and enterococcus counts and antibiotic resistance phenotypes and distribution of antimicrobial resistance determinants in Escherichia coli isolates. Environmental Microbiology, 73, 6566-6576. http://dx.doi.org/10.1128/AEM.01086-07
McMullin, P. (2004) Poultry disease. www.poultrysite.com
Majowicz, S.E., Musto, J., Scallan, E., Angulo, F.J., Kir, K.M., O-Brien, S.J., Jones, T.F., Fazil, A. and Hoekkstra, R.M. (2010) The global burden of collibacillosis. Clinical Infectious Diseases, 50, 882-889. http://dx.doi.org/10.1086/650733
Shane, S.M. (2009) Reducing pathogenic E. coli infection by vaccination. World Poultry, 25, 21-23.
Gunderson, B.W., Ross, G.H., Ibrahim, K.H. and Rotschafer, J.C. (2001) What do we really know about antibiotics. Pharmacodynamics? Pharmacotherapy, 21, 302S-318S. http://dx.doi.org/10.1592/phco.21.18.302S.33905
Wai, K.-N., Dekay, H.G. and Banker, G.S. (1996). Application of montmorrillonitse in tablet making. Journal of Pharmaceutical Sciences, 55, 1244-1248. http://dx.doi.org/10.1002/jps.2600551116
Vanderbilt, T.I. (1992). Veegum—The versatile ingredient for pharmaceutical formulations. Technical Literature, RT Vanderbilt Co., Inc., New York.
Cristina, E., Ivan, P. and Kevin, R. (2007) Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases, 2, MR17-MR71.
Schills, S. (2002) The use of clay in fight against effect of ammonia. http://www.mistalus.net
Elmore, A.R. (2003) Cosmetics ingredients review experts panel’s report. International Journal of Toxicology, 22, 37-102.
Ezeibe, M.C.O. (2006) Admacine. Federal Republic of Nigeria. Patents and Design Act. Cap. 344. LDN. 1990.
Ezeibe, M.C.O., Mbuko, I.J., Okoroafor, O.N., Okonkwo, A.C., Animoke, P.C., Orajaka, L.J.E. and Ngene, A.A. (2009) In vitro and in vivo effects of Aluminium-Magnesium Silicate on Infectious Bursal Disease virus in chikens. Animal Science Papers and Reports, 3, 132.
Ezeibe, M.C.O., Okafor, U.C., Okoroafor, O.N., Eze, J.I., Ngene, A.A., Animoke, P.C. and Mbuko, I.J. (2011) Effect of Aluminium-Magnesium Silicate on anticcocidial activity of sulphadimidine. Tropical Veterinarian, 29, 41-44.
Ezeibe, M.C.O., Ijabo, O., Uzopuo, C., Okoroafor, O.N., Eze, J.I., Mbuko, I.J., Sanda, M.E., Animoke, P.C. and Ngene, A.A. (2011) Effects of Aluminium-Magnesium Silicate on Newcastle disease virus and on recovery of infected chicks. International Journal of Biological and Chemical Sciences, 5, 825-829.
Ezeibe, M.C.O., Elendu-Eleke, N.P., Okoroafor, O.N. and Ngene, A.A. (2012) Adjuvant effect of a synthetic Aluminium-Magnesium Silicate on chloroquine phosphate, against Plasmodium berghei. Health, 4, 448-451. http://dx.doi.org/10.4236/health.2012.48071
Ezeibe, M.C.O., Anosa, G.N., Okorie, O.K., Elendu-Eleke, N.P., Okoroafor, O.N., Ngene, A.A. and Chikelu, O.N. (2012) Aluminium-Magnesium Silicate enhances antibacterial activity of Ampicillin trihydrate, against S. gallinarum. Health, 4, 675-678. http://dx.doi.org/10.4236/health.2012.49106
Ezeibe, M.C.O., Dire, C.D., Anosa, G.N., Chikelu, O.N., Okoroafor, O.N., Okorie, O.K., Ngene, A.A., Idika, I.K., Ogunniran, T.M. and Ezeala, I.E. (2012) Efficacy of piperazine citrate, stabilized with Aluminium-Magnesium Silicate, against Helignosomoides bakeri. Health, 4, 890-892. http://dx.doi.org/10.4236/health.2012.410135
Ezeibe, M.C.O., Chima, U.M., Ngene, A.A., Okoroafor, O.N., Kalu, I.I. and Esen, M.E. (2012) Effective treatment of resistant Escherichia coli infection, with sulphadimidine stabilized in a synthetic Aluminium-Magnesium Silicate. Health, 4, 1295-1298. http://dx.doi.org/10.4236/health.2012.412190
National Research Council (1994) Nutrient requirements of poultry. 9th Edition, National Academy Press, Washington DC.
Brent, W., Gunderson, Gigi, H., Ross, K.H.I. and John, C.R. (2001) What do we really know about antibiotics pharmacodynamics? Pharmacotherapy, 21, 28-31.
Kaplan, R.M. (2002) Anthelmintic resistance in nematods of horses. Veterinary Research, 33, 491-507. http://dx.doi.org/10.1051/vetres:2002035